Table 1 Clinical and diagnostic findings in Vizsla polymyopathy
From: Clinical features of idiopathic inflammatory polymyopathy in the Hungarian Vizsla
Clinical and Diagnostic Findings in VIP | Number of dogs from Group 1 | % of total Group 1 dogs (24) | Number of dogs from Group 2 | % of total Group 2 (53) | Total number of CASES with this clinical signs or had this diagnostic test out of total 77 dogs | % of total cases (77) | |
|---|---|---|---|---|---|---|---|
Dysphagia (pharyngeal phase of deglutition) | 20 | 83% | 49 | 92% | 69 | 90% | |
Drinking and eating difficulties (Oral phase of deglutition) | 21 | 87% | 48 | 91% | 69 | 90% | |
Sialorrhea | 21 | 87% | 46 | 87% | 67 | 87% | |
Masticatory muscle atrophy | 20 | 83% | 45 | 85% | 65 | 84% | |
Regurgitation | 19 | 79% | 42 | 79% | 61 | 79% | |
Trismus | 3 | 12% | 13 | 25% | 16 | 21% | |
Masticatory myalgia | 1 | 4% | 8 | 15% | 9 | 12% | |
Aspiration pneumonia | 4 | 17% | 13 | 25% | 17 | 22% | |
Toxoplasma gondii serumantibody titre (tested for and negative) | 14 | 58% | 11 | 21% | 25 | 32% | |
Neospora caninum serum antibody titre (tested for and negative) | 15 | 62% | 10 | 19% | 25 | 32% | |
Elevated serum creatine kinase (>190Â IU/L) | 18 | 75% | 23 | 43% | 41 | 53% | |
Serum creatine kinase >1000 | 11 | 46% | 14 | 26% | 25 | 32% | |
Anti- 2Â M antibody titre (Tested for and negative) | 12 | 50% | 17 | 32% | 29 | 38% | |
Anti-acetylcholine receptor antibody titre (Tested for and negative) | 16 | 67% | 16 | 30% | 32 | 42% | |
Electromyography (Performed and findings suggestive of myopathy) | 15 | 62% | 5 | 9% | 20 | 26% | |
Electromyography (Performed and findings normal) | 1 | 4% | 2 | 4% | 3 | 4% | |
Modality by which diagnosis Megaoesophagus was made | Radiographs | 8 | 33% | 18 | 34% | 26 | 34% |
Barium | 1 | 4% | 9 | 17% | 10 | 13% | |
Fluoroscopy | 4 | 17% | 8 | 15% | 12 | 16% | |